RT Journal Article
SR Electronic
T1 Seeding COVID-19 across sub-Saharan Africa: an analysis of reported importation events across 48 countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.01.20050203
DO 10.1101/2020.04.01.20050203
A1 Skrip, Laura A
A1 Selvaraj, Prashanth
A1 Hagedorn, Brittany
A1 Ouédraogo, Andre Lin
A1 Noori, Navideh
A1 Mistry, Dina
A1 Bedson, Jamie
A1 Hébert-Dufresne, Laurent
A1 Scarpino, Samuel V
A1 Althouse, Benjamin M
YR 2020
UL http://medrxiv.org/content/early/2020/06/10/2020.04.01.20050203.abstract
AB Background The first case of COVID-19 in sub-Saharan Africa (SSA) was reported by Nigeria on February 27, 2020. While case counts in the entire region remain considerably less than those being reported by individual countries in Europe, Asia, and the Americas, SSA countries remain vulnerable to COVID morbidity and mortality due to systemic healthcare weaknesses, less financial resources and infrastructure to address the new crisis, and untreated comorbidities. Variation in preparedness and response capacity as well as in data availability has raised concerns about undetected transmission events.Methods Confirmed cases reported by SSA countries were line-listed to capture epidemiological details related to early transmission events into and within countries. Data were retrieved from publicly available sources, including institutional websites, situation reports, press releases, and social media accounts, with supplementary details obtained from news articles. A data availability score was calculated for each imported case in terms of how many indicators (sex, age, travel history, date of arrival in country, reporting date of confirmation, and how detected) could be identified. We assessed the relationship between time to first importation and overall Global Health Security Index (GHSI) using Cox regression. K-means clustering grouped countries according to healthcare capacity and health and demographic risk factors.Results A total of 13,201 confirmed cases of COVID-19 were reported by 48 countries in SSA during the 54 days following the first known introduction to the region. Out of the 2516 cases for which travel history information was publicly available, 1129 (44.9%) were considered importation events. At the regional level, imported cases tended to be male (65.0%), were a median 41.0 years old (Range: 6 weeks - 88 years), and most frequently had recent travel history from Europe (53.1%). The median time to reporting an introduction was 19 days; a country’s time to report its first importation was not related to GHSI, after controlling for air traffic. Countries that had, on average, the highest case fatality rates, lowest healthcare capacity, and highest probability of premature death due to non-communicable diseases were among the last to report any cases.Conclusions Countries with systemic, demographic, and pre-existing health vulnerabilities to severe COVID-related morbidity and mortality are less likely to report any cases or may be reporting with limited public availability of information. Reporting on COVID detection and response efforts, as well as on trends in non-COVID illness and care-seeking behavior, is critical to assessing direct and indirect consequences and capacity needs in resource-constrained settings. Such assessments aid in the ability to make data-driven decisions about interventions, country priorities, and risk assessment.Key MessagesWe line-listed epidemiological indicators for the initial cases reported by 48 countries in sub-Saharan Africa by reviewing and synthesizing information provided by official institutional outlets and news sources.Our findings suggest that countries with the largest proportions of untreated comorbidities, as measured by probability of premature death due to non-communicable diseases, and the fewest healthcare resources tended to not be reporting any cases at one-month post-introduction into the region.Using data availability as a measure of gaps in detection and reporting and relating them to COVID-specific parameters for morbidity and mortality provides a measure of vulnerability.Accurate and available information on initial cases in seeding local outbreaks is key to projecting case counts and assessing the potential impact of intervention approaches, such that support for local data teams will be important as countries make decisions about control strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLAS, PS, BH, ALO, NN, DM, and BMA were funded by Bill & Melinda Gates through the Global Good Fund. LHD acknowledges support from the National Institutes of Health 1P20 GM125498-01 Centers of Biomedical Research Excellence Award. SVS is supported by startup funds provided by Northeastern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are freely available and are included as a supplement.